sulpiride has been researched along with Diabetic Retinopathy in 2 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hyperprolactinaemia generated by the dopamine D2 receptor antagonist, levosulpiride, is associated with higher levels of vasoinhibin in the vitreous of patients with DR, implying a beneficial outcome due to vasoinhibin-mediated inhibition of retinal vascular alterations." | 8.12 | Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats. ( Adán-Castro, E; Bertsch, T; Clapp, C; Díaz-Lezama, N; Martínez de la Escalera, G; Núñez, FF; Núñez-Amaro, CD; Ramírez-Hernández, G; Robles-Osorio, ML; Ruíz-Herrera, X; Siqueiros-Márquez, L; Triebel, J, 2022) |
| " Hyperprolactinaemia generated by the dopamine D2 receptor antagonist, levosulpiride, is associated with higher levels of vasoinhibin in the vitreous of patients with DR, implying a beneficial outcome due to vasoinhibin-mediated inhibition of retinal vascular alterations." | 4.12 | Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats. ( Adán-Castro, E; Bertsch, T; Clapp, C; Díaz-Lezama, N; Martínez de la Escalera, G; Núñez, FF; Núñez-Amaro, CD; Ramírez-Hernández, G; Robles-Osorio, ML; Ruíz-Herrera, X; Siqueiros-Márquez, L; Triebel, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adán-Castro, E | 1 |
| Siqueiros-Márquez, L | 1 |
| Ramírez-Hernández, G | 1 |
| Díaz-Lezama, N | 1 |
| Ruíz-Herrera, X | 1 |
| Núñez, FF | 1 |
| Núñez-Amaro, CD | 1 |
| Robles-Osorio, ML | 1 |
| Bertsch, T | 1 |
| Triebel, J | 1 |
| Martínez de la Escalera, G | 1 |
| Clapp, C | 1 |
| Verrillo, A | 1 |
| de Teresa, A | 1 |
| Martino, C | 1 |
| di Chiara, G | 1 |
2 other studies available for sulpiride and Diabetic Retinopathy
| Article | Year |
|---|---|
Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Hyperprolactinemia; Prolacti | 2022 |
Prolactin response to sulpiride in non insulin dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Insulin; Middle Aged; | 1985 |